Treace John T. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed May 14, 2024
Insider Transaction Report
Form 4
Treace John T.
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2024-05-14$5.12/sh+150,000$767,805→ 6,243,095 total
Holdings
- 408,816(indirect: By Trust)
Common Stock
- 1,605,000(indirect: By Spouse)
Common Stock
- 1,471,250(indirect: By Trust)
Common Stock
- 1,839,063(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9800 to $5.3500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]Includes 196,646 restricted stock units
- [F3]The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- [F4]The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.